英文别名(Z)-7-[(1R,2R,3S,5S)-2-[(E)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid; (Z)-7-(2-((E)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid; 5-Heptenoic acid,7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-,(1alpha(Z),2beta(1E,3S*),3alpha,5alpha)-(+-); 16-(3-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha; 16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha; SP 8103; (5Z)-7-{(1R,2R,3S,5S)-2-[(1E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoic acid; DL-cloprostenol Impurity 15S-(+/-)-cloprostenol; Cloprostenol Impurity 3(15S-(±)-Cloprostenol); (5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid 
